You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{d.Title}}
{{psData[masterIndex].Blurb}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{n.Blurb}}
{{s.Title}}
{{l.Title}}
Welcome, {{userName}}
{{'MP_HEADER_LOG_IN' | translate}}
{{countryCode}}
{{'SEARCH_MODAL_TITLE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{c.Title}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{s.Title}}
{{l.Title}}
Cell Therapy Technologies
COVID-19 Experts Discuss Exosomes and MSCS to Treat ARDS in COVID-19
Please complete the form below to access the on-demand webinar.
Role
Research scientist
Process development
Manufacturing operations
Finance
Marketing
Student
Lab management
Professor
Physician
Executive management (C-suite)
Other
Institution type
Academic research
Government research
Hospital
Bio-pharma
Cell therapy company
Contract development/manufacturing organization
Other
Country
Albania
Algeria
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia Herzegovina
Brazil
Brunei
Bulgaria
Cambodia
Canada
Chile
China
Colombia
Costa Rica
Cote d'lvoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Dominican Republic
Dutch Antilles
Ecuador
Egypt
El Salvador
Eritrea
Estonia
Ethiopia
Finland
France
French Guiana
Georgia
Germany
Greece
Guatemala
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Korea
Kuwait
Laos
Latvia
Lebanon
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malaysia
Maldives
Malta
Mauritius
Mexico
Moldova
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Nigeria
Norway
Oman
Pakistan
Palestine
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Romania
Russia
Saudi Arabia
Serbia
Seychelles
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Thailand
Togo
Trinidad and Tobago
Tunisia
Turkey
UAE
Ukraine
United Kingdom
United States
Uruguay
Uzbekistan
Vatican City
Venezuela
Vietnam
Yemen
Current stage of development
Research
Translational
Clinical Phase 1
Clinical Trial Phase 2/3
Commercial
Yes, I would like to receive future communications about Terumo BCT Cell Therapy Technologies
I confirm that I have read and agree to the
Terumo BCT Terms of Use
regarding the use of information.
*
Submit
Page Content
{{'SEARCH_MODAL_TITLE' | translate }}
{{s.Query|stripSpecialChars}}
{{'SEARCH_MODAL_OR' | translate }}
{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_PRODUCT' | translate }}
{{productCode.RefinementName}}
{{'SEARCH_MODAL_CATEGORY' | translate }}
{{categoryCode.RefinementName}}
{{'SEARCH_SMODAL_SEGMENT' | translate }}
{{segmentCode.RefinementName}}
{{'SEARCH_MODAL_SHOW_BROWSE_RESULTS' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }}
{{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}